Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 22, Issue 4, Pages 1014-1030Publisher
WILEY
DOI: 10.1111/ajt.16836
Keywords
bacteria; gut microbiota; immunosuppressive drugs; side effect; solid organ transplantation
Categories
Ask authors/readers for more resources
Understanding of the involvement of the gut microbiota in human health has significantly grown in recent decades, particularly in the fields of metabolism, inflammation, and immunology. Immunosuppressive treatments given to solid organ transplant recipients can cause changes in the gut microbiota that impact various physiological processes. Medications such as Tacrolimus and steroids induce dysbiosis and metabolic disorders, while Mycophenolate Mofetil can lead to gastrointestinal side effects.
Our understanding of the involvement of the gut microbiota (GM) in human health has expanded exponentially over the last few decades, particularly in the fields of metabolism, inflammation, and immunology. Immunosuppressive treatment (IST) prescribed to solid organ transplant (SOT) recipients produces GM changes that affect these different processes. This review aims at describing the current knowledge of how IST changes the GM. Overall, SOT followed by IST results in persistent changes in the GM, with a consistent increase in proteobacteria including opportunistic pathobionts. In mice, Tacrolimus induces dysbiosis and metabolic disorders, and alters the intestinal barrier. The transfer of the GM from Tacrolimus-treated hosts confers immunosuppressive properties, suggesting a contributory role for the GM in this drug's efficacy. Steroids induce dysbiosis and intestinal barrier alterations, and also seem to depend partly on the GM for their immunosuppressive and metabolic effects. Mycophenolate Mofetil, frequently responsible for digestive side effects such as diarrhea and colitis, is associated with pro-inflammatory dysbiosis and increased endotoxemia. Alemtuzumab, m-TOR inhibitors, and belatacept have shown more marginal impact on the GM. Most of these observations are descriptive. Future studies should explore the underlying mechanism of IST-induced dysbiosis in order to better understand their efficacy and safety characteristics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available